About FDA
Percentage of inquiries resolved via IAS Action within 10 business days of date assigned during the month
Dictionary: Globalization changed FDA’s environment for regulating products. Based on the volume of imported products, FDA identified China, India, the Middle East, Europe, and Latin America as areas in which to establish a permanent presence. These foreign posts send inquiries/requests for information to FDA headquarters. The International Affairs Staff in the Office of the Center Director is responsible for responding and/or coordinating responses with technical experts to inquiries from foreign posts concerning food and cosmetic products. This measure evaluates CFSAN's timeliness in responding to these inquiries.
Fiscal Year - 2010
| Time | Target | Percentage |
|---|---|---|
| Oct 2009 | 75 | 85 |
| Nov 2009 | 75 | 79 |
| Dec 2009 | 75 | 75 |
| Jan 2010 | 75 | 85 |
| Feb 2010 | 75 | 85 |
| Mar 2010 | 75 | 85 |
| Apr 2010 | 75 | 85 |
| May 2010 | 75 | 100 |
| Jun 2010 | 75 | 100 |
| Jul 2010 | 75 | 96 |
| Aug 2010 | 75 | 97 |
| Sep 2010 | 75 | 95 |
FY 2010 Overall: 85%
Number of inquiries resolved via IAS Action within 10 business days of date assigned during the month
Fiscal Year - 2010
| Time | Target | Number |
|---|---|---|
| Oct 2009 | N/A | 85 |
| Nov 2009 | N/A | 72 |
| Dec 2009 | N/A | 67 |
| Jan 2010 | N/A | 127 |
| Feb 2010 | N/A | 105 |
| Mar 2010 | N/A | 99 |
| Apr 2010 | N/A | 119 |
| May 2010 | N/A | 7 |
| Jun 2010 | N/A | 18 |
| Jul 2010 | N/A | 43 |
| Aug 2010 | N/A | 37 |
| Sep 2010 | N/A | 40 |
FY 2010 Total: 819
Total number of inquiries received via IAS Action during the month
Fiscal Year - 2010
| Time | Target | Number |
|---|---|---|
| Oct 2009 | N/A | 100 |
| Nov 2009 | N/A | 91 |
| Dec 2009 | N/A | 89 |
| Jan 2010 | N/A | 149 |
| Feb 2010 | N/A | 123 |
| Mar 2010 | N/A | 117 |
| Apr 2010 | N/A | 140 |
| May 2010 | N/A | 7 |
| Jun 2010 | N/A | 18 |
| Jul 2010 | N/A | 45 |
| Aug 2010 | N/A | 38 |
| Sep 2010 | N/A | 42 |
FY 2010 Total: 959
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
